MRI for Predicting Response and 10-Year Outcome of Neoadjuvant Chemotherapy with or Without Additional Bevacizumab Treatment in HER2-Negative Breast Cancer.
Saved in:
| Title: | MRI for Predicting Response and 10-Year Outcome of Neoadjuvant Chemotherapy with or Without Additional Bevacizumab Treatment in HER2-Negative Breast Cancer. |
|---|---|
| Authors: | Brandal, Siri Helene Bertelsen1,2 (AUTHOR) sibert@ous-hf.no, Mo, Torgeir2,3 (AUTHOR), Fangberget, Anne3,4 (AUTHOR), Nilsen, Line Brennhaug4,5 (AUTHOR), Geier, Oliver Marcel5,6 (AUTHOR), Bjørndal, Hilde4,6 (AUTHOR), Holmen, Marit Muri1,7 (AUTHOR), Engebråten, Olav2,7,8 (AUTHOR), Garred, Øystein9 (AUTHOR), Hole, Knut Håkon2,4,10 (AUTHOR), Seierstad, Therese1,10 (AUTHOR) |
| Source: | Cancers. Feb2026, Vol. 18 Issue 3, p393. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers18030393 |
